Related Experiment Video
Updated: Jul 5, 2026

09:18
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Fat-Fraction Quantification Using Three-Point Dixon Technique in Duchenne Muscular Dystrophy and Its Correlation With
Manisha Mohanty1, Deepak Menon1, Seena Vengalil1
1Department of Neurology, National Institute of Mental Health and Neuro-Sciences, Bangalore, India.
Muscle & Nerve
|July 3, 2026
Summary
Muscle fat fraction (MFF) measured by Dixon MRI is a promising biomarker for Duchenne muscular dystrophy (DMD). Higher baseline MFF, especially in quadriceps, predicts faster functional decline in boys with DMD.
Area of Science:
- Biomedical Imaging
- Musculoskeletal Research
- Neuromuscular Disorders
Background:
- Muscle fat fraction (MFF) quantification via Dixon MRI is an emerging, non-invasive biomarker for Duchenne muscular dystrophy (DMD).
- Understanding MFF's relationship with disease progression is crucial for monitoring DMD.
- This study investigates MFF's correlation with functional decline and genetic characteristics in DMD.
Purpose of the Study:
- To evaluate the relationship between muscle fat fraction (MFF) and disease progression in Duchenne muscular dystrophy (DMD).
- To assess the correlation of MFF with functional decline and genotypic characteristics in DMD patients.
Main Methods:
- A single-center prospective observational study included ambulatory boys with genetically confirmed DMD.
- Muscle fat fraction (MFF) of pelvic and thigh muscles was quantified using Dixon MRI.
- Functional measures (MRC sum score, NSAA, 6MWT) were assessed at baseline, 6, and 12 months.
Main Results:
- Forty boys (median age 8 years) participated. Gluteal muscles showed the highest MFF, hamstrings the lowest.
- MFF strongly inversely correlated with all functional measures across most muscle groups.
- Baseline quadriceps MFF showed the strongest correlation with the rate of 6MWT decline over one year.
Conclusions:
- Baseline MFF, particularly in the quadriceps, predicts functional decline in ambulatory DMD patients.
- Genotype-specific adductor muscle involvement suggests variant-specific spatial differences in DMD.
- Longitudinal studies with genotype-phenotype analysis are needed to validate MFF as a biomarker for DMD clinical trials.

